Company intelligence / Profile preview

BioPharma Global

United States

Ownership: Private
Development stage: Other

Overview

BioPharma Global is a US-based, mission-driven regulatory affairs consulting firm focused on FDA and EMA submissions and strategy for orphan drugs, rare diseases, and other indications with high unmet medical need; it does not develop its own therapeutic pipeline but supports sponsors in obtaining orphan drug designations, expedited review statuses, and INDs.

Therapeutic areas: Rare Diseases
Industry: Consulting

Partnerships

Pace Life Sciences

Beyond the preview

Go deeper on BioPharma Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioPharma Global.

Explore the full profile